Inactivating Mutations of the Human Luteinizing Hormone Receptor in Both Sexes

Ana Claudia Latronico; Ivo J. P. Arnhold

doi:10.1055/s-0032-1324721

Seminars in Reproductive Medicine, Inhaltsverzeichnis

Semin Reprod Med 2012; 30(05): 382-386
DOI: 10.1055/s-0032-1324721

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Inactivating Mutations of the Human Luteinizing Hormone Receptor in Both Sexes

Ana Claudia Latronico

¹Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular LIM/42, Disciplina de Endocrinologia, Hospital das Clinicas, Faculdade de Medicina da Universidade de São Paulo

,

Ivo J. P. Arnhold

¹Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular LIM/42, Disciplina de Endocrinologia, Hospital das Clinicas, Faculdade de Medicina da Universidade de São Paulo

› Institutsangaben

Abstract

The human luteinizing hormone/chorionic gonadotropin receptor (LHCGR) plays a fundamental role in male and female reproductive physiology. Over the past 15 years, several homozygous or compound heterozygous loss-of-function mutations in the LHCGR gene have been described in males and females. In genetic males, mutations in LHCGR were associated with distinct degrees of impairment in pre- and postnatal testosterone secretion resulting in a phenotypic spectrum. Patients with the severe form of LH resistance have predominantly female external genitalia and absence of secondary sex differentiation at puberty. Patients with milder forms have predominantly male external genitalia with micropenis and/or hypospadias or only infertility without ambiguity. The undermasculization is associated with low basal, as well as human CG-stimulated, testosterone levels and elevated LH levels after pubertal age, without abnormal step-up in testosterone biosynthesis precursors. The testes have only slightly reduced size but mature Leydig cells are absent or scarce (Leydig cell hypoplasia). Genetic females with inactivating LHCGR mutations have female external genitalia, spontaneous breast and pubic hair development at puberty, and normal or late menarche followed by oligoamenorrhea and infertility. Estradiol and progesterone levels are normal for the early to midfollicular phase, but do not reach ovulatory or luteal phase levels. Serum LH levels are high whereas follicle-stimulating hormone levels are normal or only slightly increased. Pelvic ultrasound has demonstrated a small or normal uterus and normal or enlarged ovaries with cysts. The inactivating mutations of the LHCGR have provided important insights into distinct physiological roles of LH in reproduction of both sexes.

Keywords

LH receptor - Leydig cell hypoplasia - amenorrhea - infertility

Volltext

Referenzen

References
1 Ascoli M, Fanelli F, Segaloff DL. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev 2002; 23 (2) 141-174
2 Segaloff DL. Diseases associated with mutations of the human lutropin receptor. Prog Mol Biol Transl Sci 2009; 89: 97-114
3 Kossack N, Simoni M, Richter-Unruh A, Themmen APN, Gromoll J. Mutations in a novel, cryptic exon of the luteinizing hormone/chorionic gonadotropin receptor gene cause male pseudohermaphroditism. PLoS Med 2008; 5 (4) e88
4 Berthezène F, Forest MG, Grimaud JA, Claustrat B, Mornex R. Leydig-cell agenesis: a cause of male pseudohermaphroditism. N Engl J Med 1976; 295 (18) 969-972
5 Kremer H, Kraaij R, Toledo SPA , et al. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet 1995; 9 (2) 160-164
6 Latronico AC, Anasti J, Arnhold IJP , et al. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormonereceptor receptor gene. N Engl J Med 1996; 334: 507-512
7 Laue L, Wu SM, Kudo M , et al. A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet 1995; 4 (8) 1429-1433
8 Laue LL, Wu SM, Kudo M , et al. Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol Endocrinol 1996; 10 (8) 987-997
9 Misrahi M, Meduri G, Pissard S , et al. Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor. J Clin Endocrinol Metab 1997; 82 (7) 2159-2165
10 Martens JWM, Verhoef-Post M, Abelin N , et al. A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype. Mol Endocrinol 1998; 12 (6) 775-784
11 Gromoll J, Eiholzer U, Nieschlag E, Simoni M. Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab 2000; 85 (6) 2281-2286
12 Müller T, Gromoll J, Simoni M. Absence of exon 10 of the human luteinizing hormone (LH) receptor impairs LH, but not human chorionic gonadotropin action. J Clin Endocrinol Metab 2003; 88 (5) 2242-2249
13 Latronico AC, Chai Y, Arnhold IJP, Liu X, Mendonca BB, Segaloff DL. A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol Endocrinol 1998; 12 (3) 442-450
14 Toledo SPA, Brunner HG, Kraaij R , et al. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J Clin Endocrinol Metab 1996; 81 (11) 3850-3854
15 Stavrou SS, Zhu YS, Cai LQ , et al. A novel mutation of the human luteinizing hormone receptor in 46XY and 46XX sisters. J Clin Endocrinol Metab 1998; 83 (6) 2091-2098
16 Qiao J, Han B, Liu BL , et al. A splice site mutation combined with a novel missense mutation of LHCGR cause male pseudohermaphroditism. Hum Mutat 2009; 30 (9) E855-E865
17 Huhtaniemi I, Alevizaki M. Gonadotrophin resistance. Best Pract Res Clin Endocrinol Metab 2006; 20 (4) 561-576
18 Richard N, Leprince C, Gruchy N , et al. Identification by array-Comparative Genomic Hybridization (array-CGH) of a large deletion of luteinizing hormone receptor gene combined with a missense mutation in a patient diagnosed with a 46,XY disorder of sex development and application to prenatal diagnosis. Endocr J 2011; 58 (9) 769-776
19 Latronico AC, Segaloff DL. Naturally occurring mutations of the luteinizing-hormone receptor: lessons learned about reproductive physiology and G protein-coupled receptors. Am J Hum Genet 1999; 65 (4) 949-958 Review
20 Themmen APN. An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms. Reproduction 2005; 130 (3) 263-274
21 Bruysters M, Christin-Maitre S, Verhoef-Post M , et al. A new LH receptor splice mutation responsible for male hypogonadism with subnormal sperm production in the propositus, and infertility with regular cycles in an affected sister. Hum Reprod 2008; 23 (8) 1917-1923
22 Yariz KO, Walsh T, Uzak A , et al. Inherited mutation of the luteinizing hormone/choriogonadotropin receptor (LHCGR) in empty follicle syndrome. Fertil Steril 2011; 96 (2) e125-e130
23 Zreik TG, Garcia-Velasco JA, Vergara TM, Arici A, Olive D, Jones EE. Empty follicle syndrome: evidence for recurrence. Hum Reprod 2000; 15 (5) 999-1002
24 Onalan G, Pabuçcu R, Onalan R, Ceylaner S, Selam B. Empty follicle syndrome in two sisters with three cycles: case report. Hum Reprod 2003; 18 (9) 1864-1867
25 Vujisic S, Stipoljev F, Bauman R, Dmitrovic R, Jezek D. Pericentric inversion of chromosome 2 in a patient with the empty follicle syndrome: case report. Hum Reprod 2005; 20 (9) 2552-2555
26 Arnhold IJ, Latronico AC, Batista MC, Izzo CR, Mendonca BB. Clinical features of women with resistance to luteinizing hormone. Clin Endocrinol (Oxf) 1999; 51 (6) 701-707
27 Zhang FP, Poutanen M, Wilbertz J, Huhtaniemi I. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol 2001; 15 (1) 172-183
28 Lei ZM, Mishra S, Zou W , et al. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol Endocrinol 2001; 15 (1) 184-200